Phase III clinical trial results at the 48th Union World Conference on Lung Health: Implications for the field

DR-TB STAT
Nov. 25, 2017, 7:53 p.m.
post image

Preliminary results from two phase III drug-resistant TB (DR-TB) clinical trials were presented at the 48th Union World Conference on Lung Health: stage 1 of the STREAM trial and the Otsuka 213 delamanid trial.

DR-TB STAT has released a statement reviewing the findings of these studies as presented at the Conference and reviewed later with the study investigators, and discussing possible implications for decisions made at country level, while formal WHO review and recommendations are pending.

The statement can be accessed here.